MDGL
Madrigal Pharmaceuticals Inc
Price:  
312.77 
USD
Volume:  
207,499.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDGL WACC - Weighted Average Cost of Capital

The WACC of Madrigal Pharmaceuticals Inc (MDGL) is 9.4%.

The Cost of Equity of Madrigal Pharmaceuticals Inc (MDGL) is 9.55%.
The Cost of Debt of Madrigal Pharmaceuticals Inc (MDGL) is 5.00%.

Range Selected
Cost of equity 8.30% - 10.80% 9.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 8.2% - 10.6% 9.4%
WACC

MDGL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.97 1.05
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.30% 10.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.02 0.02
Cost of debt 5.00% 5.00%
After-tax WACC 8.2% 10.6%
Selected WACC 9.4%